The effect of risk-minimizing pharmacovigilance measures on the prescription of anti-biotics in Iceland and the Nordic countries
Background: Fluoroquinolones are broad-spectrum antibiotics with rare but serious side effects. In October 2018, following a safety referral the EMA recommended restricting fluoroquinolone use due to safety concerns. Objective: To assess the impact of pharmacovigilance actions on fluoroquinolone pre...
Main Author: | |
---|---|
Other Authors: | |
Format: | Master Thesis |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | http://hdl.handle.net/1946/46522 |
id |
ftskemman:oai:skemman.is:1946/46522 |
---|---|
record_format |
openpolar |
spelling |
ftskemman:oai:skemman.is:1946/46522 2024-05-19T07:42:26+00:00 The effect of risk-minimizing pharmacovigilance measures on the prescription of anti-biotics in Iceland and the Nordic countries Petra Ósk Guðbjargardóttir 1998- Háskóli Íslands 2024-04 application/pdf http://hdl.handle.net/1946/46522 en eng http://hdl.handle.net/1946/46522 Lyfjafræði Thesis Master's 2024 ftskemman 2024-04-23T23:40:09Z Background: Fluoroquinolones are broad-spectrum antibiotics with rare but serious side effects. In October 2018, following a safety referral the EMA recommended restricting fluoroquinolone use due to safety concerns. Objective: To assess the impact of pharmacovigilance actions on fluoroquinolone prescriptions in Iceland and to compare to Nordic countries. Methods: A retrospective nationwide cohort study analysing antibiotic prescriptions in Iceland over the years 2013-2023. Additionally, the prescription rates were compared to the prescription rates in Norway, Sweden and Denmark. Finally, spontaneous reporting rates from Vigibase data was also analysed. Results: Antibiotic prescriptions, including fluoroquinolones, decreased in Iceland during the period after the pharmacovigilance actions were taken (2019-2023) compared to the period before (2013-2018). However, almost all of the most commonly anti-biotics had a decrease, except for broad spectrum penicillin. Iceland's antibiotic use remains higher than in the Nordic countries. Limited number of spontaneous reports were received for fluoroquinolones over the study period, however, a spike in the reports was noted in 2019 following the safety referral. Conclusion: Fluoroquinolone use decreased in Iceland after the pharmacovigilance actions were implemented, but other factors likely also played a role because overall anti-biotic prescription rates decreased during the period. Master Thesis Iceland Skemman (Iceland) |
institution |
Open Polar |
collection |
Skemman (Iceland) |
op_collection_id |
ftskemman |
language |
English |
topic |
Lyfjafræði |
spellingShingle |
Lyfjafræði Petra Ósk Guðbjargardóttir 1998- The effect of risk-minimizing pharmacovigilance measures on the prescription of anti-biotics in Iceland and the Nordic countries |
topic_facet |
Lyfjafræði |
description |
Background: Fluoroquinolones are broad-spectrum antibiotics with rare but serious side effects. In October 2018, following a safety referral the EMA recommended restricting fluoroquinolone use due to safety concerns. Objective: To assess the impact of pharmacovigilance actions on fluoroquinolone prescriptions in Iceland and to compare to Nordic countries. Methods: A retrospective nationwide cohort study analysing antibiotic prescriptions in Iceland over the years 2013-2023. Additionally, the prescription rates were compared to the prescription rates in Norway, Sweden and Denmark. Finally, spontaneous reporting rates from Vigibase data was also analysed. Results: Antibiotic prescriptions, including fluoroquinolones, decreased in Iceland during the period after the pharmacovigilance actions were taken (2019-2023) compared to the period before (2013-2018). However, almost all of the most commonly anti-biotics had a decrease, except for broad spectrum penicillin. Iceland's antibiotic use remains higher than in the Nordic countries. Limited number of spontaneous reports were received for fluoroquinolones over the study period, however, a spike in the reports was noted in 2019 following the safety referral. Conclusion: Fluoroquinolone use decreased in Iceland after the pharmacovigilance actions were implemented, but other factors likely also played a role because overall anti-biotic prescription rates decreased during the period. |
author2 |
Háskóli Íslands |
format |
Master Thesis |
author |
Petra Ósk Guðbjargardóttir 1998- |
author_facet |
Petra Ósk Guðbjargardóttir 1998- |
author_sort |
Petra Ósk Guðbjargardóttir 1998- |
title |
The effect of risk-minimizing pharmacovigilance measures on the prescription of anti-biotics in Iceland and the Nordic countries |
title_short |
The effect of risk-minimizing pharmacovigilance measures on the prescription of anti-biotics in Iceland and the Nordic countries |
title_full |
The effect of risk-minimizing pharmacovigilance measures on the prescription of anti-biotics in Iceland and the Nordic countries |
title_fullStr |
The effect of risk-minimizing pharmacovigilance measures on the prescription of anti-biotics in Iceland and the Nordic countries |
title_full_unstemmed |
The effect of risk-minimizing pharmacovigilance measures on the prescription of anti-biotics in Iceland and the Nordic countries |
title_sort |
effect of risk-minimizing pharmacovigilance measures on the prescription of anti-biotics in iceland and the nordic countries |
publishDate |
2024 |
url |
http://hdl.handle.net/1946/46522 |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
http://hdl.handle.net/1946/46522 |
_version_ |
1799482115620864000 |